Angiotensin (1-7): A new link in the renin-angiotensin-aldosterone system (RAAS)
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue
Abstract
The discovery of a new angiotensin-converting enzyme (ACE2) and studies of the biological activity of angiotensin (1-7) indicate the complexity of the functioning of the renin-angiotensin-aldosterone system (RAAS). In this paper the activities of angiotensin (1-7) are summarized. Angiotensin (1-7) has vasodilating, antiproliferative, antifibrotic, and antithrombotic properties which antagonize the action of angiotensin II. This indicates new possibilities for the future use of these effects for better treatment efficiency of cardiovascular diseases.
Authors and Affiliations
Dariusz Andrzejczak
Current views on etiopathogenesis of systemic lupus erythematosus
The article is a review of information concerning etiopathogenesis of systemic lupus erythematosus (SLE). Due to the risk of serious complications, including death, the clarification of etiology could result in substanti...
Bakterie, wirusy i odczyn zapalny w podwzgórzu: Nowe czynniki w patogenezie otyłości
Acridines as antitumor drugs
Acridines belong to a group of polycyclic heteroaromatic compounds and exhibit a broad spectrum of biological activity including antiprotozoal, antibacterial, antiviral and antitumor activity. Acridine derivatives with...
The frequency of myeloid and lymphoid dendritic cells in multiple myeloma patients is inversely correlated with disease progression
Multiple myeloma (MM) is a neoplastic disease characterized by proliferation and prolonged survival of clonal plasma cells, most frequently occurring in the bone marrow, but also in other tissues. Dendritic cells (DCs) a...
Subkliniczne zmiany miażdżycowe tętnic szyjnych i czynniki ryzyka sercowo-naczyniowego u pacjentów zakażonych HIV
Wstęp: U osób zakażonych HIV, zwłaszca leczonych antyretrowirusowo, obserwuje się zwiększone ryzyko i występowanie chorób sercowo-naczyniowych. Cele pracy: Celem pracy jest ocena zaawansowania subklinicznych zmian miażdż...